
Journal of Medicinal Chemistry p. 1470 - 1476 (1990)
Update date:2022-08-04
Topics:
Cavalleri
Turconi
Tamborini
Occelli
Cietto
Pallanza
Scotti
Berti
Romano
Parenti
A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.
View MoreBeijing Stable Chemcial Co.ltd
Contact:86-10-63785052
Address:A1301 Technological Edifice. No.4 FuFeng Road,FengTai District, Beijing. China
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Xi'an Tizan Tech & Industry Co., Ltd.
Contact:86-18629066522
Address:C3009 TANG FENG INTERNATIONAL PLAZA, NO.18 FENGHUI NAN ROAD, XI'AN HIGH TECH ZONE, 710075 CHINA.
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Twin International Co., Limited
Contact:+86-21-80309280
Address:No.345 Jinxiang Road, Jinqiao Export Processing Zone
Doi:10.1002/hlca.19560390524
(1956)Doi:10.1016/j.tet.2008.12.016
(2009)Doi:10.1021/jo00242a049
(1988)Doi:10.1039/c5cc03421c
(2015)Doi:10.1039/C39870000662
(1987)Doi:10.1021/ol802946p
(2009)